1. Home
  2. Analysis
  3. Ribapak
  4. Claritin

Ribapak and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribapak (ribavirin) and Claritin (loratadine). Common drug interactions include nausea among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Ribapak and Claritin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Ribapak?

Ribapak has active ingredients of ribavirin. eHealthMe is studying from 3,392 Ribapak users. Check the latest studies of Ribapak.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

On Jul, 07, 2026

22 people who take Ribapak and Claritin together, and have interactions are studied.

Ribapak and Claritin drug interactions.

What are the common drug interactions of Ribapak and Claritin, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Depression
  3. Headache (pain in head)
  4. Abdominal discomfort
  5. Anxiety
  6. Dysgeusia (disorder of the sense of taste)
  7. Fatigue (feeling of tiredness)
  8. Insomnia (sleeplessness)
  9. Irritability
  10. Pancreatitis acute (sudden inflammation of pancreas)

male:

  1. Fatigue (feeling of tiredness)
  2. Influenza like illness
  3. Cardiac flutter (abnormal heart rhythm)
  4. Cough
  5. Decreased appetite
  6. Depression
  7. Diarrhoea
  8. Dizziness
  9. Headache (pain in head)
  10. Injection site reaction

What are the common drug interactions of Ribapak and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Insomnia (sleeplessness)
  2. Pruritus generalised (generalized itching)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Depression
  5. Diarrhoea
  6. Headache (pain in head)
  7. Irritability
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Abdominal pain
  10. Ageusia (loss of taste functions of the tongue)

60+:

  1. Asthenia (weakness)
  2. Cardiac flutter (abnormal heart rhythm)
  3. Visual acuity reduced (reduced clearness of vision)
  4. Depression
  5. Dizziness
  6. Fatigue (feeling of tiredness)
  7. Injection site reaction
  8. Lethargy (tiredness)
  9. Migraine with aura (headache with vision weakness)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

What are the existing conditions these people have? *

  1. Hepatitis C: 10 people, 45.45%
  2. Multiple Myeloma (cancer of the plasma cells): 6 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Ribapak and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ribapak and Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ribapak:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribapak and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and loratadine (the active ingredients of Ribapak and Claritin, respectively), and Ribapak and Claritin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.